nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.0399	0.0399	CcSEcCtD
Cefotaxime—Colitis—Vandetanib—thyroid cancer	0.0293	0.0293	CcSEcCtD
Cefotaxime—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.0269	0.0269	CcSEcCtD
Cefotaxime—Dermatitis bullous—Vandetanib—thyroid cancer	0.0232	0.0232	CcSEcCtD
Cefotaxime—Injection site inflammation—Epirubicin—thyroid cancer	0.0228	0.0228	CcSEcCtD
Cefotaxime—Injection site inflammation—Doxorubicin—thyroid cancer	0.0211	0.0211	CcSEcCtD
Cefotaxime—Bullous eruption—Epirubicin—thyroid cancer	0.0193	0.0193	CcSEcCtD
Cefotaxime—Bronchospasm—Vandetanib—thyroid cancer	0.0189	0.0189	CcSEcCtD
Cefotaxime—Neutropenia—Vandetanib—thyroid cancer	0.0179	0.0179	CcSEcCtD
Cefotaxime—Bullous eruption—Doxorubicin—thyroid cancer	0.0178	0.0178	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0171	0.0171	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0169	0.0169	CcSEcCtD
Cefotaxime—Renal failure—Vandetanib—thyroid cancer	0.0168	0.0168	CcSEcCtD
Cefotaxime—Haemoglobin—Vandetanib—thyroid cancer	0.0154	0.0154	CcSEcCtD
Cefotaxime—Haemorrhage—Vandetanib—thyroid cancer	0.0153	0.0153	CcSEcCtD
Cefotaxime—Erythema multiforme—Vandetanib—thyroid cancer	0.0145	0.0145	CcSEcCtD
Cefotaxime—Local reaction—Epirubicin—thyroid cancer	0.0138	0.0138	CcSEcCtD
Cefotaxime—Arrhythmia—Vandetanib—thyroid cancer	0.0137	0.0137	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Cefotaxime—Local reaction—Doxorubicin—thyroid cancer	0.0127	0.0127	CcSEcCtD
Cefotaxime—Neutropenia—Sorafenib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Cefotaxime—Convulsion—Vandetanib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Cefotaxime—Renal failure—Sorafenib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Cefotaxime—Jaundice—Sorafenib—thyroid cancer	0.0112	0.0112	CcSEcCtD
Cefotaxime—Thrombocytopenia—Vandetanib—thyroid cancer	0.0107	0.0107	CcSEcCtD
Cefotaxime—Haemoglobin—Sorafenib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Cefotaxime—Haemorrhage—Sorafenib—thyroid cancer	0.0103	0.0103	CcSEcCtD
Cefotaxime—Erythema multiforme—Sorafenib—thyroid cancer	0.00979	0.00979	CcSEcCtD
Cefotaxime—Pain—Vandetanib—thyroid cancer	0.00932	0.00932	CcSEcCtD
Cefotaxime—Arrhythmia—Sorafenib—thyroid cancer	0.00925	0.00925	CcSEcCtD
Cefotaxime—Liver injury—Epirubicin—thyroid cancer	0.00905	0.00905	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00891	0.00891	CcSEcCtD
Cefotaxime—Body temperature increased—Vandetanib—thyroid cancer	0.00862	0.00862	CcSEcCtD
Cefotaxime—Abdominal pain—Vandetanib—thyroid cancer	0.00862	0.00862	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—thyroid cancer	0.00838	0.00838	CcSEcCtD
Cefotaxime—Angioedema—Sorafenib—thyroid cancer	0.00823	0.00823	CcSEcCtD
Cefotaxime—Leukopenia—Sorafenib—thyroid cancer	0.00806	0.00806	CcSEcCtD
Cefotaxime—Pruritus—Vandetanib—thyroid cancer	0.00771	0.00771	CcSEcCtD
Cefotaxime—Vaginal inflammation—Epirubicin—thyroid cancer	0.00762	0.00762	CcSEcCtD
Cefotaxime—Diarrhoea—Vandetanib—thyroid cancer	0.00746	0.00746	CcSEcCtD
Cefotaxime—Anaphylactic shock—Sorafenib—thyroid cancer	0.00735	0.00735	CcSEcCtD
Cefotaxime—Colitis—Epirubicin—thyroid cancer	0.00731	0.00731	CcSEcCtD
Cefotaxime—Candida infection—Epirubicin—thyroid cancer	0.00727	0.00727	CcSEcCtD
Cefotaxime—Shock—Sorafenib—thyroid cancer	0.00723	0.00723	CcSEcCtD
Cefotaxime—Thrombocytopenia—Sorafenib—thyroid cancer	0.0072	0.0072	CcSEcCtD
Cefotaxime—Vaginal infection—Epirubicin—thyroid cancer	0.00719	0.00719	CcSEcCtD
Cefotaxime—Aplastic anaemia—Epirubicin—thyroid cancer	0.00715	0.00715	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00705	0.00705	CcSEcCtD
Cefotaxime—Vomiting—Vandetanib—thyroid cancer	0.00693	0.00693	CcSEcCtD
Cefotaxime—Rash—Vandetanib—thyroid cancer	0.00687	0.00687	CcSEcCtD
Cefotaxime—Dermatitis—Vandetanib—thyroid cancer	0.00687	0.00687	CcSEcCtD
Cefotaxime—Headache—Vandetanib—thyroid cancer	0.00683	0.00683	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—thyroid cancer	0.00677	0.00677	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—thyroid cancer	0.00673	0.00673	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—thyroid cancer	0.00665	0.00665	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00662	0.00662	CcSEcCtD
Cefotaxime—Nausea—Vandetanib—thyroid cancer	0.00647	0.00647	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00633	0.00633	CcSEcCtD
Cefotaxime—Pain—Sorafenib—thyroid cancer	0.00629	0.00629	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00601	0.00601	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00585	0.00585	CcSEcCtD
Cefotaxime—Urticaria—Sorafenib—thyroid cancer	0.00584	0.00584	CcSEcCtD
Cefotaxime—Body temperature increased—Sorafenib—thyroid cancer	0.00581	0.00581	CcSEcCtD
Cefotaxime—Abdominal pain—Sorafenib—thyroid cancer	0.00581	0.00581	CcSEcCtD
Cefotaxime—Renal impairment—Epirubicin—thyroid cancer	0.00581	0.00581	CcSEcCtD
Cefotaxime—Dermatitis bullous—Epirubicin—thyroid cancer	0.00578	0.00578	CcSEcCtD
Cefotaxime—Hypersensitivity—Sorafenib—thyroid cancer	0.00542	0.00542	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—thyroid cancer	0.00538	0.00538	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00535	0.00535	CcSEcCtD
Cefotaxime—Pruritus—Sorafenib—thyroid cancer	0.0052	0.0052	CcSEcCtD
Cefotaxime—Diarrhoea—Sorafenib—thyroid cancer	0.00503	0.00503	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00498	0.00498	CcSEcCtD
Cefotaxime—Eosinophilia—Epirubicin—thyroid cancer	0.00473	0.00473	CcSEcCtD
Cefotaxime—Vomiting—Sorafenib—thyroid cancer	0.00468	0.00468	CcSEcCtD
Cefotaxime—Rash—Sorafenib—thyroid cancer	0.00464	0.00464	CcSEcCtD
Cefotaxime—Dermatitis—Sorafenib—thyroid cancer	0.00463	0.00463	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00461	0.00461	CcSEcCtD
Cefotaxime—Headache—Sorafenib—thyroid cancer	0.00461	0.00461	CcSEcCtD
Cefotaxime—Neutropenia—Epirubicin—thyroid cancer	0.00447	0.00447	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—thyroid cancer	0.00438	0.00438	CcSEcCtD
Cefotaxime—Nausea—Sorafenib—thyroid cancer	0.00437	0.00437	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00422	0.00422	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—thyroid cancer	0.00419	0.00419	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—thyroid cancer	0.00415	0.00415	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—thyroid cancer	0.00413	0.00413	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—thyroid cancer	0.00398	0.00398	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00391	0.00391	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—thyroid cancer	0.00388	0.00388	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—thyroid cancer	0.00384	0.00384	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—thyroid cancer	0.00384	0.00384	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—thyroid cancer	0.00368	0.00368	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—thyroid cancer	0.00362	0.00362	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—thyroid cancer	0.00356	0.00356	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—thyroid cancer	0.00354	0.00354	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—thyroid cancer	0.00354	0.00354	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—thyroid cancer	0.00316	0.00316	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—thyroid cancer	0.00309	0.00309	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—thyroid cancer	0.00288	0.00288	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—thyroid cancer	0.00278	0.00278	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—thyroid cancer	0.00272	0.00272	CcSEcCtD
Cefotaxime—Shock—Epirubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—thyroid cancer	0.00266	0.00266	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Cefotaxime—Pain—Epirubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Cefotaxime—Rash—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Cefotaxime—Headache—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
